Bessemer Group
RMD icon

Bessemer Group’s ResMed RMD Stock Holding History

Bessemer Group’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$833K Buy
3,711
+246
+7% +$61.3K ﹤0.01% 984
2025
Q4 		$836K Buy
3,465
+90
+3% +$23K ﹤0.01% 1003
2025
Q3 		$924K Buy
3,375
+125
+4% +$34.1K ﹤0.01% 670
2025
Q2 		$838K Sell
3,250
-3,117
-49% -$744K ﹤0.01% 673
2025
Q1 		$1.43M Sell
6,367
-9,220
-59% -$2.15M ﹤0.01% 570
2024
Q4 		$3.56M Sell
15,587
-51
-0.3% -$12.3K 0.01% 501
2024
Q3 		$3.82M Buy
15,638
+13,831
+765% +$3.09M 0.01% 497
2024
Q2 		$346K Buy
1,807
+82
+5% +$16.6K ﹤0.01% 887
2024
Q1 		$342K Buy
1,725
+221
+15% +$40.5K ﹤0.01% 900
2023
Q4 		$258K Buy
1,504
+194
+15% +$29.8K ﹤0.01% 980
2023
Q3 		$194K Sell
1,310
-2,697
-67% -$488K ﹤0.01% 1044
2023
Q2 		$876K Sell
4,007
-2,323
-37% -$518K ﹤0.01% 682
2023
Q1 		$1.39M Sell
6,330
-203
-3% -$44K ﹤0.01% 524
2022
Q4 		$1.36M Sell
6,533
-2,219
-25% -$488K ﹤0.01% 525
2022
Q3 		$1.91M Buy
8,752
+374
+4% +$85.1K 0.01% 460
2022
Q2 		$1.76M Sell
8,378
-719
-8% -$153K ﹤0.01% 463
2022
Q1 		$2.21M Buy
9,097
+1,185
+15% +$287K ﹤0.01% 337
2021
Q4 		$2.06M Buy
7,912
+627
+9% +$163K ﹤0.01% 340
2021
Q3 		$1.92M Sell
7,285
-34
-0.5% -$9.3K ﹤0.01% 316
2021
Q2 		$1.8M Buy
7,319
+364
+5% +$76.5K ﹤0.01% 329
2021
Q1 		$1.35M Buy
6,955
+13
+0.2% +$2.61K ﹤0.01% 371
2020
Q4 		$1.48M Buy
6,942
+119
+2% +$23.7K ﹤0.01% 339
2020
Q3 		$1.17M Sell
6,823
-4,651
-41% -$859K ﹤0.01% 385
2020
Q2 		$2.2M Buy
11,474
+5,965
+108% +$976K 0.01% 454
2020
Q1 		$810K Buy
5,509
+377
+7% +$60K ﹤0.01% 658
2019
Q4 		$796K Sell
5,132
-100
-2% -$14.4K ﹤0.01% 797
2019
Q3 		$707K Sell
5,232
-457
-8% -$59.9K ﹤0.01% 783
2019
Q2 		$694K Sell
5,689
-5
-0.1% -$554 ﹤0.01% 794
2019
Q1 		$592K Sell
5,694
-1,321
-19% -$136K ﹤0.01% 758
2018
Q4 		$798K Buy
7,015
+4,843
+223% +$519K ﹤0.01% 633
2018
Q3 		$251K Buy
2,172
+1,083
+99% +$119K ﹤0.01% 940
2018
Q2 		$113K Sell
1,089
-15
-1% -$1.52K ﹤0.01% 1085
2018
Q1 		$109K Buy
1,104
+13
+1% +$1.23K ﹤0.01% 1104
2017
Q4 		$92K Buy
1,091
+120
+12% +$9.91K ﹤0.01% 1150
2017
Q3 		$75K Buy
971
+171
+21% +$13.1K ﹤0.01% 1234
2017
Q2 		$62K Hold
800
– – ﹤0.01% 1267
2017
Q1 		$58K Hold
800
– – ﹤0.01% 1274
2016
Q4 		$50K Sell
800
-289
-27% -$17.7K ﹤0.01% 1355
2016
Q3 		$71K Buy
1,089
+289
+36% +$19.2K ﹤0.01% 1161
2016
Q2 		$51K Hold
800
– – ﹤0.01% 861
2016
Q1 		$46K Sell
800
-80,000
-99% -$4.53M ﹤0.01% 917
2015
Q4 		$4.34M Hold
80,800
– – 0.02% 284
2015
Q3 		$4.12M Sell
80,800
-13,706
-15% -$738K 0.02% 287
2015
Q2 		$5.33M Buy
94,506
+80,000
+551% +$5.05M 0.03% 254
2015
Q1 		$1.04M Buy
14,506
+3,406
+31% +$221K 0.01% 517
2014
Q4 		$622K Buy
+11,100
New +$580K ﹤0.01% 554

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bessemer Group's RMD Position: Q1 2026 in Review

Bessemer Group increased its ResMed (RMD) stake by 7.1% in Q1 2026, buying an estimated $61.3K and bringing the position to 3,711 shares worth $833K. The position accounts for ﹤0.01% of the portfolio, ranked #984.

Bessemer Group first reported a position in RMD in Q4 2014 and has held it in 46 quarters since. The position peaked at $5.33M in Q2 2015. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Bessemer Group held 3,711 shares of ResMed worth $833K as of Q1 2026.
  • Bessemer Group bought 246 ResMed shares in Q1 2026, an estimated $61.3K.
  • ResMed made up ﹤0.01% of Bessemer Group's portfolio in Q1 2026, its #984 holding.
  • Bessemer Group first reported a position in ResMed in Q4 2014 and has held it in 46 quarters since.
  • Bessemer Group's ResMed position peaked at $5.33M in Q2 2015.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Bessemer Group's 13F filing for Q1 2026, filed 6 May 2026.